Overview
Tenoxicam, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.
Indication
用于类风湿性关节炎、退行性关节病、关节强直性脊柱炎；关节外病变如肌腱炎、黏液囊炎、肩或髋关节周围炎、劳损及扭伤、急性痛风等。
Associated Conditions
- Back pain
- Osteoarthritis (OA)
- Pain
- Rheumatoid Arthritis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/09/26 | Not Applicable | Completed | |||
2025/01/22 | Phase 4 | Active, not recruiting | Haydarpasa Numune Training and Research Hospital | ||
2024/08/27 | Phase 1 | Active, not recruiting | |||
2022/08/11 | Phase 1 | Completed | |||
2022/03/23 | Not Applicable | Completed | Nevsehir Haci Bektas Veli University | ||
2020/03/19 | Not Applicable | Not yet recruiting | |||
2019/12/02 | Phase 4 | Completed | |||
2015/09/15 | Phase 2 | UNKNOWN | |||
2014/11/07 | Phase 4 | Completed | T.C. ORDU ÜNİVERSİTESİ | ||
2014/06/10 | Phase 4 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| XOTILON TAB 20MG | N/A | N/A | N/A | 9/25/1996 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| TENOXICAM | 02230510 | Tablet - Oral | 20 MG | N/A | |
| MOBIFLEX TAB 20MG | Hoffmann-La Roche Limited | 00884367 | Tablet - Oral | 20 MG / TAB | 12/31/1991 |
| TENOXICAM | aa pharma inc | 02230661 | Tablet - Oral | 20 MG | 2/21/1997 |
| TENOXICAM-20 | PRO DOC LIMITEE | 02231120 | Tablet - Oral | 20 MG | 11/24/1998 |
| NOVO-TENOXICAM TAB 20MG | novopharm limited | 02231314 | Tablet - Oral | 20 MG | 6/5/1997 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| REUTENOX 20 mg GRANULADO PARA SUSPENSION ORAL | Laboratorios Rubio S.A. | 60557 | GRANULADO PARA SUSPENSIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
| REUTENOX 20 mg COMPRIMIDOS RECUBIERTOS | Laboratorios Rubio S.A. | 58665 | COMPRIMIDO RECUBIERTO | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.